Sabrina Brem

Suggest Changes
Learn More
2001 Background: EMD 121974 (cilengitide) is a selective integrin receptor inhibitor that is well tolerated and has demonstrated biological activity in patients with malignant glioma. The objectives(More)
2015 Background: Neurocognitive function (NCF) protection and tumor control are goals of brain metastasis (BM) therapy. Whole brain radiation therapy (WBRT) reduces recurrence after surgery but has(More)
2077 Background: NCCN guidelines for brain metastases (BM) endorse surgery and whole brain radiation therapy (WBRT). Early clinical data suggest that addition of intracavitary carmustine wafers(More)
  • 1